ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Stock Forecast

Stock Price Forecast

The 22 analysts that cover ACADIA Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $30, which forecasts a 11.69% increase in the stock price over the next year. The lowest target is $17 and the highest is $40.

Price Target: $30 (+11.69%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$30	$31	$40
Change	-36.71%	+11.69%	+15.41%	+48.92%

Analyst Ratings

The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	4	5	6	6	7	7
Buy	8	8	8	8	8	8
Hold	7	7	6	6	7	6
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	20	21	21	21	23	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $33 → $36	Strong Buy	Maintains	$33 → $36	+34.03%	Jan 6, 2026
Ashwani Verma UBS	UBS	Strong Buy Maintains $35 → $40	Strong Buy	Maintains	$35 → $40	+48.92%	Jan 6, 2026
Ananda Ghosh HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $32 → $37	Strong Buy	Maintains	$32 → $37	+37.75%	Dec 15, 2025
Paul Matteis Stifel	Stifel	Hold Maintains $24 → $25	Hold	Maintains	$24 → $25	-6.92%	Dec 11, 2025
Uy Ear Mizuho	Mizuho	Hold Maintains $24 → $29	Hold	Maintains	$24 → $29	+7.97%	Dec 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.10B

Increased by 15.16%

from 957.80M

Revenue Next Year

1.23B

Increased by 11.51%

from 1.10B

EPS This Year

0.82

Decreased by -39.44%

from 1.36

EPS Next Year

0.81

Decreased by -2.24%

from 0.82

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	441.76M	484.15M	517.24M	726.44M	957.80M	1.10B	1.23B
Revenue Growth	30.28%	9.60%	6.83%	40.45%	31.85%	15.16%	11.51%
EPS	-1.79	-1.05	-1.34	-0.37	1.36	0.82	0.81
EPS Growth	-	-	-	-	-	-39.44%	-2.24%
Forward PE	-	-	-	-	-	32.61	33.36
No. Analysts	-	-	-	-	-	22	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.1B	1.4B
Avg	1.1B	1.2B
Low	1.1B	1.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	19.2%	25.4%
Avg	15.2%	11.5%
Low	9.7%	2.9%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	1.03	1.25
Avg	0.82	0.81
Low	0.54	0.40

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-24.3%	51.7%
Avg	-39.4%	-2.2%
Low	-60.4%	-51.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.